BlackRock’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

BlackRock’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-150,000	Closed	-$4.03M	–	5061
2020 Q1	$4.03M	Sell	150,000 -585,000	-80%	-$16.6M	﹤0.01%	3440
2019 Q4	$22M	Sell	735,000 -85,000	-10%	-$2.31M	﹤0.01%	2823
2019 Q3	$20.1M	Buy	820,000 +620,000	+310%	+$16.4M	﹤0.01%	2819
2019 Q2	$5.44M	Buy	+200,000	New	+$5.26M	﹤0.01%	3508

Other funds holding IDNA

RCS

Retirement Capital Strategies San Jose, California $265M AUM 11.86% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

BlackRock's IDNA Position: Q2 2020 in Review

BlackRock sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2020, closing a stake of 150,000 shares — an estimated $4.03M sold.

BlackRock first reported a position in IDNA in Q2 2019 and held it in 4 quarters. The position peaked at $22M in Q4 2019. 37 funds tracked by Wall St. Rank hold IDNA as of Q2 2020.

BlackRock reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2020 after selling out during the quarter.
BlackRock sold 150,000 iShares Genomics Immunology and Healthcare ETF shares in Q2 2020, an estimated $4.03M.
BlackRock first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2019 and held it in 4 quarters.
BlackRock's iShares Genomics Immunology and Healthcare ETF position peaked at $22M in Q4 2019.
37 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2020.

Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.